A clean energy company spun off from Ohio State and backed by Bill Gates has raised $246 million. Koloma, based in Denver but with a lab in Columbus, has developed technology to extract carbon-free hydrogen from underground deposits.

Basking Biosciences, a company developing a novel therapy to treat stroke, raised $55 million from a group of investors including The Ohio State University. Every year, 15 million people suffer strokes and more than 5 million die, according to the World Health Organization.

Several of Ohio’s biggest names in healthcare are teaming up for a first-of-its-kind partnership to produce and commercialize pediatric medical devices. With support from a $6.95 million grant from the Food and Drug Administration (FDA), Nationwide Children’s Hospital and The Ohio State University are leading the Midwest Pediatric Device Consortium - the first of its kind in the Midwest.

Clarametyx Biosciences, a Columbus-based BioTech startup, has raised a $33 million Series A round to advance its cutting-edge anti-biofilm biologics for combating serious bacterial infections. The company, founded in 2020, specializes in developing targeted, immune-empowering biologic therapies to address persistent infections linked to biofilms.

Columbus-based software consultancy Test Double has acquired product consultancy Pathfinder Product thanks to complementary services, a shared vision, and two degrees of Kevin Bacon.

Columbus-based Forge Biologics, a gene therapy development startup, announced they're to be acquired by Japanese Ajinomoto Co., Inc. for $620 million.

It’s hard to keep up with all the news about data center projects in the Columbus area, which has become one of the country’s top 10 regions for such facilities.